1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Hormonal Contraception Global Clinical Trials Review, H2, 2015

Hormonal Contraception Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Hormonal Contraception Global Clinical Trials Review, H2, 2015" provides an overview of Hormonal Contraception clinical trials scenario. This report provides top line data relating to the clinical trials on Hormonal Contraception. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Hormonal Contraception Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hormonal Contraception to Women's Health Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hormonal Contraception to Women's Health Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Hormonal Contraception Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Hormonal Contraception 32
Oct 19, 2015: Agile Therapeutics Announces Completion of Patient Enrollment in Twirla Phase 3 SECURE Clinical Trial 32
Clinical Trial Profile Snapshots 33
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 70

List of Tables
Hormonal Contraception Therapeutics, Global, Clinical Trials by Region, 2015* 6
Hormonal Contraception Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Hormonal Contraception Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hormonal Contraception Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Hormonal Contraception Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Hormonal Contraception Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Hormonal Contraception Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Hormonal Contraception Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Hormonal Contraception to Women's Health Clinical Trials, G7 Countries (%), 2015* 15
Hormonal Contraception Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Hormonal Contraception Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Hormonal Contraception to Women's Health Clinical Trials, E7 Countries (%), 2015* 18
Hormonal Contraception Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Hormonal Contraception Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Hormonal Contraception Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Hormonal Contraception Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Hormonal Contraception Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Hormonal Contraception Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Hormonal Contraception Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Hormonal Contraception Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Hormonal Contraception Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Hormonal Contraception Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Hormonal Contraception Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31

List of Figures
Hormonal Contraception Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Hormonal Contraception Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Hormonal Contraception Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hormonal Contraception Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Hormonal Contraception Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Hormonal Contraception Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Hormonal Contraception Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Hormonal Contraception Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Hormonal Contraception to Women's Health Clinical Trials, G7 Countries (%), 2015* 15
Hormonal Contraception Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Hormonal Contraception Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Hormonal Contraception to Women's Health Clinical Trials, E7 Countries (%), 2015* 18
Hormonal Contraception Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Hormonal Contraception Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Hormonal Contraception Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Hormonal Contraception Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Hormonal Contraception Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Hormonal Contraception Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Hormonal Contraception Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Hormonal Contraception Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Hormonal Contraception Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Hormonal Contraception Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Hormonal Contraception Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 68

Companies mentioned
Bayer AG
Merck and Co., Inc.
Johnson and Johnson
Teva Pharmaceutical Industries Limited
Pfizer Inc.
Pantarhei Bioscience BV
Laboratorios Leon Farma, S.A.
Agile Therapeutics, Inc.
Allergan Plc
Aegerion Pharmaceuticals, Inc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Hormonal Contraceptives Market Analysis & Trends -Product Type (Injection, Implantation, Intrauterine Device (IUD), Oral Pill, Skin Patch), Hormone, Method - Forecast to 2025

Global Hormonal Contraceptives Market Analysis & Trends -Product Type (Injection, Implantation, Intrauterine Device (IUD), Oral Pill, Skin Patch), Hormone, Method - Forecast to 2025

  • $ 4200
  • Industry report
  • October 2016
  • by Accuray Research LLP

The Global Hormonal Contraceptives Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2025. Some of the prominent trends that the market is witnessing ...

Global Hormonal Contraception Market Research Report 2016

Global Hormonal Contraception Market Research Report 2016

  • $ 2850
  • Industry report
  • November 2016
  • by 9Dimen Research

2016 Global Hormonal Contraception Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Hormonal Contraception industry, focusing on the ...

IMS Country Review 2016: Mexico

IMS Country Review 2016: Mexico

  • $ 3670
  • Industry report
  • July 2016
  • by IMS Health

IMS Country Review™ 2016 provides comprehensive qualitative insights into a specific pharmaceutical market as well as showing sales trends over the last 5 years. Sales performance is analysed in terms ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.